The initiation of our collaboration with Mr. Ty-Minh Tan, aiming at strengthening the international development of Karabinis Medical SA, was announced by the President & Managing Director of the company, Mr. Apostolos Karabinis, who commented as below: “I am extremely glad to welcome Mr. Ty-Minh Tan to Karabinis Medical ecosystem. Our long friendship and our trust to Mr. Tan’s moral principles and business abilities assure the significancy of his contribution to the internationalization of our activities, enabling us to provide high quality health care products and services to more people around the globe! »
Karabinis Medical Award by the World Pharmacists
For the long and substantial support to the valuable work of the World Pharmacists, the President and CEO of Karabinis Medical SA, Mr. Apostolos Karabinis, was awarded on Sunday, February 19, during an event held at the Athens Concert Hall, as part of the 14th Health Expo.
Addressing the President, Mrs. Dora Manolakou and all the members and friends of the organization, Mr. Karabinis said: “It’s both our duty and pleasure to return value, doing the best possible for ours and future generations wellbeing on a peaceful and better planet. From my heart I want to congratulate Dora Manolakou and her wonderful team, all the supporters for the amazing, heartfelt work they are doing through time, alleviating the adversities faced by many of our fellow people worldwide.”
Changes in the management of KARABINIS MEDICAL S.A.
Athens, December 17, 2020
The founder of KARABINIS MEDICAL S.A., Mr. Apostolos Karampinis, within the framework of the company’s development needs takes over the full management of the company and once more the duties of President and CEO. His long-term international business experience, as well as his experience in leading the company will ensure the implementation of new business plans focusing on the company’s further economic and business development, both in Greece and in major foreign markets. Mr. Stefanos Tsitsimpis, after his ten-year service with KARABINIS MEDICAL S.A. in the position in the Accounting Department, as well as in the positions of CFO and Chairman of the Board of Directors for the last four years, will maintain close cooperation with the company as financial advisor.
Mr. Apostolos Karampinis stated: “I would like to thank Mr. Stefanos Tsitsimpis for his great contribution to the progress of our company during all these years he worked with passion for our ecosystem. Due to the increased duties of the position of President and CEO, I personally take over the leadership of the company, focusing on the further development of KARABINIS MEDICAL S.A., which is the core of my international business activities.”
Antimicrobial Thermometer and how it acts against viruses and microbes providing greater safety than standard thermometers
Athens, February 14, 2020. Mr. Apostolos Karabinis, Founder & Entrepreneur of KARABINIS MEDICAL SA, has signed a significant agreement with Microlife USA CEO Mark Porter to promote KARABINIS MEDICAL’s innovative antimicrobial thermometer in USA!
The antimicrobial thermometer having been granted the European and American patent is available in Germany and Greece, and following the trade agreement with Microlife USA it will be launched in USA offering great added value to the health market.
The effective action of the antimicrobial digital thermometer has certified by several clinical studies published in many significant journals such as the American Journal of Emergency Medicines. In addition, the antimicrobial thermometer has received international awards for its documented and patented application against the spread of germs versus the simple digital thermometers.
Through its patented technology application, it aims to create conditions of safe temperature management not only for the family, but also for the whole “health chain” (doctors – nurses – patients).
The innovative digital antimicrobial copper thermometer provides the best solution for hygiene and safe fever management.
- Reduces the risk of transmission of germs among users
- Provides accurate thermometry
- The antimicrobial activity of copper significantly reduces the pathogenic germs
The antimicrobial copper used in this thermometer has been shown in a variety of clinical studies to kill a wide range of pathogenic microbes, such as Klebsiella spp, Staphylococcus Aureus, Staphylococcus epidermidis, Candida spp, Pseudomonas spp, Influenza A (H1N1).
Specifying the subject of the antimicrobial activity of copper, it is extremely important to refer to a research study by Professor William Keevil (Centre for Biological Sciences, University of Southampton, United Kingdom), «Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials» (American Society for Microbiology 2015 6 (6): e01697-15).
The study documented the drastic and rapid reduction of Human Coronavirus 229E coronaviruses, strains responsible for the MERS-Co Middle East Respiratory Syndrome flu, when they come in contact with antimicrobial copper surfaces, where they are exposed to stainless steel, remained unchanged throughout the study.
Mr Apostolos Karabinis noticed that it was a great pleasure for KARABINIS MEDICAL to promote the first digital antimicrobial thermometer, a Greek patent, which could provide one more shield against viruses and germs.
KARABINIS MEDICAL antimicrobial thermometer is available in Greece under the name Microlife MT410 and consumers can obtain it from pharmacies, the official KARABINS MEDICAL product promotion network.
Microlife Antimicrobial thermometer
Athens, February 21st, 2018.
The new antimicrobial thermometer Microlife MT 410 provides a safe, fast and hygienic temperature measurement.
- Reduces the risk of microbial cross-contamination among users
- Provides accurate temperature measurement in 10 seconds
- The nature of antimicrobial copper reduces drastically the pathogenicmicrobes
Through its patented technological application, aims to create safe thermometry conditions, not only to families but to the entire healthcare chain (doctors-nurses-patients).
The antimicrobial copper which is applied on the thermometer’s tip and battery’s cover kills a wide range of pathogenic microbes, drastically reducing microbial flora on the coated parts and causes significant pathogenic microbes reduction at the rest body of the thermometer.
The result of its continuous and ongoing antimicrobial action is the decrease of pathogenic microbes spreading, providing high safety and protection to the user.
Extensive laboratory and clinical studies worldwide have shown that a large number of bacteria, viruses and fungi cannot survive on the antimicrobial copper surfaces.
The health of your heart is… in safe hands! New Microlife Campaign
New President & Managing Director
Athens, February 24, 2017. Mr. Apostolos Karabinis, main shareholder and up to now President and Managing Director of KARABINIS MEDICAL S.A, promotes the General Manager of the company, Mr. Stefanos Tsitsimpis, as President & Managing Director of KARABINIS MEDICAL S.A.
Mr. Apostolos Karabinis stated:
“After many years of successful course in the company and his progress as the General Manager of KARABINIS MEDICAL S.A, Mr. Stefanos Tsitsimpis proved himself as a totally qualified officer, possessing the necessary skills and experience required to lead the company, having as fundamental orientation its further financial and business development, always at the service of our partners and consumers. I hereby assign the central administration of the company in his experienced hands, with confidence that he will perfectly meet the demands of new duties. With this administrative change and having created a sound corporate structure, now I can dedicate my productive time in the development of our business activities in major overseas markets as well as in research and development products under global patents, through our new company MEKYLON SA.
In any case, these entire activities also support our central company in Greece, KARABINIS MEDICAL S.A. Obviously, I will continue to actively support KARABINIS MEDICAL S.A alongside, as it has been my entire business core during the last 50 years of operation”.
The antimicrobial thermometer in Arab Health 2017
Athens, February 10, 2017
The product Antimicrobial Thermometer of KARABINIS MEDICAL, integrated into the MICROLIFE product range, attracted visitors attention during the largest international exhibition in Middle East, the Arab Health 2017, held in Dubai, on January 30 to February 2nd.
Mr. Apostolos Karabinis, President & CEO of KARABINIS MEDICAL, accompanied by Mr. George Stamatiou, Development Director of the company, attended the exhibition and the booth of MICROLIFE. Moreover, they had important meetings with representatives of international companies from the health sector.
Presentation of the antimicrobial thermometer in Expopharm Germany
Athens, October 19, 2016. KARABINIS MEDICAL antimicrobial thermometer now integrated in the Microlife product range was presented in the International Pharmaceutical Exhibition Expopharm, in Munich, Germany, from Wednesday, 12 October to Saturday, 15 October 2016.
The Expopharm is an international pharmaceutical trade fair, which has established itself as a leading European trade fair for the pharmacy sector. It takes place once a year and it was founded in 1949 as “pharmaceutical exhibition”. Today it announces the most important innovations from all areas of the pharmacy world such as pharmaceuticals, food supplements, natural remedies but also pharmacy equipment and technical literature
Every year it attracts the interest of global health market, while visited by more than 28,000 professionals and 500 exhibitors, half of them not German, presenting new products.
The antimicrobial thermometer, as new innovative health product, attracted the visitors’ attention. KARABINIS MEDICAL President & CEO, Mr.Apostolos Karabinis stated: “It is a great pleasure of our company and mine personally, to get presented within such an important trade fair, the product I dreamt, designed and implemented. I’m confident that this product will receive high acceptance by the consumers in the near future”.
The agreement on the first antimicrobial thermometer promotion in the global health market was signed between Mr.Karabinis and MICROLIFE on May 18, 2016 and just five months later the product was launched in the International health market.
New Corporate Branding
[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][fusion_text]Athens, May 13, 2015. KARABINIS MEDICAL has been a strong and successful Greek company in the health field for the past 48 years. With relations of trust and major achievements as its main features, dominates in the Greek market with powerful strategic collaborations and world innovative firsts. Evidently, the time has come to change its corporate identity in order to get perfectly synchronized with its enlarged strategic and business objectives and its orientation towards international markets.
Blue and petrol the colors of the new corporate identity, clearly reminding the field of medicine and health, beneficially impact psychology, creating associations with nature
The horse, symbol of the company’s logo and part of its history, still present and connected with KARABINIS MEDICAL name, is now expressed in a new form. This horse reflects everything this company stands for: it ties up with the DNA strand and in free rough design simultaneously captures history, purpose, development and the new dynamic goals of the company
The new corporate message, “Value for life” aimed at extroversion, emphasizes the timeless values and vision of KARABINIS MEDICAL.
Into this new era of development and progress, KARABINIS MEDICAL continuing with knowledge, responsibility and advanced scientific thought to generate health value- the fundamental asset for man- becomes a major leader in the map of global health.[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]